Moderna on Monday said the latest analysis showed that its vaccine was 100% effective at preventing severe disease from COVID-19. The pharma major added that its primary analysis which included 196 cases, found the vaccine to be 94.1% effective. The company now plans to request clearance for emergency use of the vaccine in the US and Europe.